Recent Advances in the Use of Molecular Analyses to Inform the Diagnosis and Prognosis of Patients with Polycythaemia Vera

por Stuckey, Ruth, Gómez-Casares, María Teresa
Publicado 2021

CALR mutation characterization in myeloproliferative neoplasms

por Bilbao-Sieyro, Cristina, Florido, Yanira, Gómez-Casares, María Teresa
Publicado 2016

Discontinuation of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia: a Review of the Biological Factors Associated with Treatment-Free Remission

por Stuckey, Ruth, López Rodríguez, Juan Francisco, Gómez-Casares, María Teresa
Publicado 2022

Molecular Studies for the Early Detection of Philadelphia-Negative Myeloproliferative Neoplasms

por Stuckey, Ruth, Bilbao-Sieyro, Cristina, Segura-Díaz, Adrián, Gómez-Casares, María Teresa
Publicado 2023

Positive Impact of Eculizumab Therapy on Surgery for Budd-Chiari Syndrome in a Patient with Paroxysmal Nocturnal Hemoglobinuria and a Long-Term History of Thrombosis

por De-la-Iglesia, Silvia, Luzardo, Hugo, Lemes, Angelina, Torres, Melissa, Gómez-Casares, Maria Teresa, Cruz, Naylen, Molero, Teresa
Publicado 2016

Integration of molecular testing for the personalized management of patients with diffuse large B-cell lymphoma and follicular lymphoma

por Stuckey, Ruth, Luzardo Henríquez, Hugo, de la Nuez Melian, Haridian, Rivero Vera, José Carlos, Bilbao-Sieyro, Cristina, Gómez-Casares, María Teresa
Publicado 2023

Predictive indicators of successful tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia

por Stuckey, Ruth, López-Rodríguez, Juan Francisco, Sánchez-Sosa, Santiago, Segura-Díaz, Adrián, Sánchez-Farías, Nuria, Bilbao-Sieyro, Cristina, Gómez-Casares, María Teresa
Publicado 2020

Cost-effectiveness of Ruxolitinib vs Best Available Therapy in the Treatment of Myelofibrosis in Spain

por Gómez-Casares, María Teresa, Hernández-Boluda, Juan Carlos, Jiménez-Velasco, Antonio, Martínez-López, Joaquin, Ferrario, María Giovanna, Gozalbo, Irmina, Gostkorzewicz, Joana, Subirá, Rudi
Publicado 2017

High Resolution Melting Analysis: A Rapid and Accurate Method to Detect CALR Mutations

por Bilbao-Sieyro, Cristina, Santana, Guillermo, Moreno, Melania, Torres, Laura, Santana-Lopez, Gonzalo, Rodriguez-Medina, Carlos, Perera, María, Bellosillo, Beatriz, de la Iglesia, Silvia, Molero, Teresa, Gomez-Casares, Maria Teresa
Publicado 2014

Presence of Myeloid Mutations in Patients with Chronic Myeloid Leukemia Increases Risk of Cardiovascular Event on Tyrosine Kinase Inhibitor Treatment

por Stuckey, Ruth, Segura-Díaz, Adrián, Sáez Perdomo, María Nieves, Pérez Encinas, Manuel Mateo, González San Miguel, Jóse David, Florido, Yanira, Sánchez-Sosa, Santiago, López-Rodríguez, Juan Francisco, Bilbao-Sieyro, Cristina, Gómez-Casares, María Teresa
Publicado 2023

Janus kinase inhibitor ruxolitinib in combination with nilotinib and prednisone in patients with myelofibrosis (RuNiC study): A phase Ib, multicenter study

por Ayala, Rosa, Fernández, Rafael Alonso, García‐Gutiérrez, Valentín, Alvarez‐Larrán, Alberto, Osorio, Santiago, Sánchez‐Pina, Jose M., Carreño‐Tarragona, Gonzalo, Álvarez, Noemi, Gómez‐Casares, María Teresa, Duran, Antonia, Gorrochategi, Julian, Hernández‐Boluda, Juan Carlos, Martínez‐López, Joaquín
Publicado 2023

BCL2 Expression at Post-Induction and Complete Remission Impact Outcome in Acute Myeloid Leukemia

por Bilbao-Sieyro, Cristina, Rodríguez-Medina, Carlos, Florido, Yanira, Stuckey, Ruth, Sáez, María Nieves, Sánchez-Sosa, Santiago, González Martín, Jesús María, Santana, Guillermo, González-Pérez, Elena, Cruz-Cruz, Naylén, Fernández, Rosa, Molero Labarta, Teresa, Gomez-Casares, María Teresa
Publicado 2020

Prediction of major bleeding events in 1381 patients with essential thrombocythemia

por Stuckey, Ruth, Ianotto, Jean-Christophe, Santoro, Marco, Czyż, Anna, Encinas, Manuel M. Perez, Gómez-Casares, María Teresa, Pereira, Maria Soledad Noya, de Nałęcz, Anna Kulikowska, Gołos, Aleksandra, Lewandowski, Krzysztof, Szukalski, Łukasz, González-Martín, Jesús M., Sobas, Marta Anna
Publicado 2023

Can the Gene Expression Profile of Patients with Acute Myeloid Leukemia Predict Complete Remission Following Induction Therapy?

por Sánchez-Sosa, Santiago, Rodríguez-Medina, Carlos, Stuckey, Ruth, Florido, Yanira, Santana, Guillermo, González Martín, Jesús María, Cruz-Cruz, Naylén, Torres-Ochando, Melissa, Fernández, Rosa, Sánchez-Farías, Nuria, Cionfrini, Antonia, Labarta, Teresa Molero, Gomez-Casares, María Teresa, Bilbao-Sieyro, Cristina
Publicado 2022

Impact of Individual Comorbidities on Survival of Patients with Myelofibrosis

por García-Fortes, María, Hernández-Boluda, Juan C., Álvarez-Larrán, Alberto, Raya, José M., Angona, Anna, Estrada, Natalia, Fox, Laura, Cuevas, Beatriz, García-Hernández, María C., Gómez-Casares, María Teresa, Ferrer-Marín, Francisca, Saavedra, Silvana, Cervantes, Francisco, García-Delgado, Regina
Publicado 2022

Thrombotic Risk Detection in Patients with Polycythemia Vera: The Predictive Role of DNMT3A/TET2/ASXL1 Mutations

por Segura-Díaz, Adrián, Stuckey, Ruth, Florido, Yanira, González-Martín, Jesús María, López-Rodríguez, Juan Francisco, Sánchez-Sosa, Santiago, González-Pérez, Elena, Perdomo, María Nieves Sáez, Perera, María del Mar, de la Iglesia, Silvia, Molero-Labarta, Teresa, Gómez-Casares, María Teresa, Bilbao-Sieyro, Cristina
Publicado 2020

Genetic Testing at Diagnosis Has Prognostic Value in Patients with Chronic Lymphocytic Leukemia including at Early Stages

por Suárez-Cabrera, Alexia, Fiallo-Suárez, Dolly Viviana, Stuckey, Ruth, Uroz-de la Iglesia, Marta Luna, Florido, Yanira, Lemes-Castellano, Angelina, Perera-Álvarez, Miguel Ángel, Luzardo-Henríquez, Hugo, de la Nuez, Haridian, Fernández-Caldas, Paula, de la Iglesia, Silvia, Gómez-Casares, María Teresa, Bilbao-Sieyro, Cristina
Publicado 2022

Durable treatment-free remission in patients with chronic myeloid leukemia in chronic phase following frontline nilotinib: 96-week update of the ENESTfreedom study

por Ross, David M., Masszi, Tamas, Gómez Casares, María Teresa, Hellmann, Andrzej, Stentoft, Jesper, Conneally, Eibhlin, Garcia-Gutierrez, Valentin, Gattermann, Norbert, le Coutre, Philipp D., Martino, Bruno, Saussele, Susanne, Giles, Francis J., Radich, Jerald P., Saglio, Giuseppe, Deng, Weiping, Krunic, Nancy, Bédoucha, Véronique, Gopalakrishna, Prashanth, Hochhaus, Andreas
Publicado 2018

PTCH1 is a reliable marker for predicting imatinib response in chronic myeloid leukemia patients in chronic phase

por Alonso-Dominguez, Juan M., Casado, Luis Felipe, Anguita, Eduardo, Gomez-Casares, Maria Teresa, Buño, Ismael, Ferrer-Marín, Francisca, Arenas, Alicia, Del Orbe, Rafael, Ayala, Rosa, Llamas, Pilar, Salgado, Rocio N., Osorio, Santiago, Sanchez-Godoy, Pedro, Burgaleta, Carmen, Mahíllo-Fernández, Ignacio, Garcia-Gutierrez, Valentin, Steegmann, Juan Luis, Martinez-Lopez, Joaquín
Publicado 2017

An analysis of the kinetics of molecular response during the first trimester of treatment with nilotinib in newly diagnosed chronic myeloid leukemia patients in chronic phase

por Steegmann, Juan Luis, Colomer, Dolors, Gómez-Casares, Maria-Teresa, García-Gutiérrez, Valentín, Ortí, Guillermo, Ramírez-Payer, Angel, Olavarria, Eduardo, Vall-llovera, Ferrán, Giraldo, Pilar, Conde, Eulogio, Vallansot, Rolando, López-Lorenzo, Jose Luis, Palomera, Luis, Álvarez-Larrán, Alberto, Conesa, Venancio, Bautista, Guiomar, Casas, Laura, Giles, Frank, Hochhaus, Andreas, Casado-Montero, Luis Felipe
Publicado 2017